Equities

Farmsintez PAO

Farmsintez PAO

Actions
  • Price (RUB)4.52
  • Today's Change-0.285 / -5.94%
  • Shares traded31.05m
  • 1 Year change-27.76%
  • Beta--
Data delayed at least 30 minutes, as of Jun 24 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Farmsintez PAO (Farmsintez OJSC) is a Russia-based company, which is engaged in the pharmaceutical sector. The Company focuses on the medical research, development and manufacture of drugs ingredients used in oncology, gynecology, tuberculosis therapy and others. In addition, Farmsintez OAO offers chemical research services, chemical technology development and quality control services. The Company sells its products domestically, as well as abroad, including the Commonwealth of Independence State (CIS) countries. It has two wholly owned subsidiaries located in Moscow and Tallin, Estonia. As of May 21, 2011, the Company’s major shareholder was EphaG AS with a stake of 69.23%. In April 2013, the Company acquired the pharmacies of Guardum Pharmaceuticals in the U.S. state of Florida.

  • Revenue in RUB (TTM)438.33m
  • Net income in RUB-697.55m
  • Incorporated2003
  • Employees119.00
  • Location
    Farmsintez PAOKrasnogo Kursanta25 litera ZH, BTS IT ParkSAINT PETERSBURG 188663Russian FederationRUS
  • Phone+7 8 123298080
  • Fax+7 8 123298089
  • Websitehttp://en.pharmsynthez.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shield Therapeutics PLC127.64m-853.79m1.84bn16.00--0.5501--14.42-0.0817-0.08170.01220.23630.0430.53481.54121,812.50-28.76-24.56-30.15-27.0361.3189.95-668.91-199.8717.86-451.480.00--1,344.65--70.11---29.49--
Herantis Pharma Oyj0.00-719.67m1.85bn-----------1.14-1.140.00-0.09770.00-------105.59-65.71-136.72-79.09-----------40.691.19-------39.49------
Arctic Bioscience AS-541.78bn-541.78bn1.91bn--------------------------------------------------4.97---88.48------
Bioextrax AB publ1.89m-59.46m1.93bn----73.13--1,020.38-0.7651-0.76510.02430.320.054--3.37---169.98---254.58---155.43---3,150.09-----3,073.810.00--1,166.12---89.02------
Shedir Pharma Srl Unipersonale2.43bn193.85m1.93bn71.009.971.385.940.79540.30090.30093.772.180.90221.396.53545,683.607.26--9.78--57.66--8.04--2.057.880.3601---14.28--38.34------
ISR Immune System Rgultn Hldg AB (publ)0.00-414.25m1.93bn----9.53-----1.10-1.100.000.55840.00-------161.95-111.37-208.84-155.17-----------13,101.500.0256-------152.98------
Farmsintez PAO438.33m-697.55m1.95bn119.00--3.94--4.44-2.32-2.321.461.150.25215.241.63---40.12-21.01-95.59-28.7736.7438.24-159.14-175.640.1712-5.550.6723--17.94-7.90-32.91---61.63--
RTA Laboratuvarlari Biyoljik UI v MST AS1.22bn361.96m1.95bn100.005.401.974.661.602.652.658.947.280.950311.183.813,843,417.0031.4727.2853.7839.5040.5741.5233.1231.211.69--0.14020.0066.7864.6087.8794.7455.18--
Verici Dx Plc0.00-444.89m1.95bn12.00--2.54-----0.0479-0.04790.000.069------0.00--------------------0.00-------75.92------
Vivesto AB137.82m-621.63m1.95bn19.00--0.5201--14.17-0.2496-0.24960.05631.320.03431.444.941,188,864.00-15.47---18.08---68.59---451.04--6.11-30.480.0116--------------
Tissue Regenix Group PLC1.45bn-351.00m1.96bn79.00--0.7887--1.35-0.0008-0.00080.00310.00540.41231.185.18279,534.80-10.41-21.22-11.23-23.2542.9446.54-25.25-66.702.83-5.950.1922---6.5159.1170.02--8.02--
4d Pharma PLC34.19m-3.53bn1.97bn95.00--1.29--57.56-0.3361-0.33610.00310.12870.0133--0.19375,494.74-137.72-56.02-161.03-62.60-----10,337.17-11,690.925.16-157.990.2998---2.25---107.83---38.56--
Scandion Oncology A/S0.00-142.90m1.97bn----2.13-----0.7745-0.77450.004.100.00-------14.79---15.68--------------0.0106-------217.81------
SoftOx Solutions AS40.46m-363.96m2.01bn----4.36--49.72-7.02-7.020.76448.240.0716--1.03---64.43-44.89-74.64-54.35-----899.50-540.762.17-210.150.0554---19.69139.15-74.85------
Destiny Pharma PLC0.00-349.68m2.02bn18.00--3.35-----0.0892-0.08920.000.12540.00----0.00-48.57-41.12-53.54-43.98------------0.00------1.32------
Data as of Jun 24 2022. Currency figures normalised to Farmsintez PAO's reporting currency: Russian Ruble RUB
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.